Can we recommend mirtazapine and bupropion for patients at risk for bleeding?: A systematic review and meta-analysis
Journal of Affective Disorders | Aug 17, 2017
Na KS, et al. – The objective was to conduct a systematic review and meta–analysis to examine an evidence–based approach for the bleeding risks of mirtazapine and bupropion. The results seemed to suggest that it is premature to recommend mirtazapine and bupropion for patients who have a bleeding risk.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
